Literature DB >> 27421294

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009.

.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27421294      PMCID： PMC5014087          DOI： 10.1177/1203475416655705

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN： 1203-4754            Impact factor:   2.092


× No keyword cloud information.
  6 in total

Review 1.  Emerging paradigm shift toward proactive topical treatment of psoriasis: A narrative review.

Authors:  Kim A Papp; Gurbir Dhadwal; Melinda Gooderham; Lyn Guenther; Irina Turchin; Marni Wiseman; Jensen Yeung
Journal:  Dermatol Ther       Date:  2021-09-14       Impact factor: 3.858

2.  Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study.

Authors:  C-H Hong; K A Papp; K W Lophaven; P Skallerup; S Philipp
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-09-14       Impact factor: 6.166

Review 3.  Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab.

Authors:  Todd Wechter; Abigail Cline; Steven R Feldman
Journal:  Ther Clin Risk Manag       Date:  2018-08-22       Impact factor: 2.423

4.  Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomized, controlled trial.

Authors:  C Bodemer; A Kaszuba; K Kingo; A Tsianakas; A Morita; E Rivas; P Papanastasiou; D Keefe; M Patekar; P Charef; L Zhang; S Cafoncelli; C Papavassilis
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-01-19       Impact factor: 6.166

Review 5.  Exploring Biologic Treatment Hesitancy Among Black and Indigenous Populations in Canada: a Review.

Authors:  Edgar Akuffo-Addo; Theodora Udounwa; Jocelyn Chan; Laura Cauchi
Journal:  J Racial Ethn Health Disparities       Date:  2022-04-27

6.  Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS).

Authors:  Charles W Lynde; Maryam S Alam; Kamal Ohson; Angélique Gagné-Henley; Miriam Avadisian; Ronald B Vender
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.